KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Operating Margin: 2009-2024

Historic Operating Margin for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to -10.47%.

  • Pacira BioSciences' Operating Margin rose 8631.00% to 3.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.80%, marking a year-over-year increase of 1514.00%. This contributed to the annual value of -10.47% for FY2024, which is 2346.00% down from last year.
  • As of FY2024, Pacira BioSciences' Operating Margin stood at -10.47%, which was down 180.58% from 12.99% recorded in FY2023.
  • In the past 5 years, Pacira BioSciences' Operating Margin ranged from a high of 16.61% in FY2021 and a low of -10.47% during FY2024.
  • For the 3-year period, Pacira BioSciences' Operating Margin averaged around 3.84%, with its median value being 9.00% (2022).
  • Per our database at Business Quant, Pacira BioSciences' Operating Margin soared by 830bps in 2020 and then slumped by 2,346bps in 2024.
  • Pacira BioSciences' Operating Margin (Yearly) stood at 10.79% in 2020, then surged by 582bps to 16.61% in 2021, then plummeted by 760bps to 9.00% in 2022, then spiked by 399bps to 12.99% in 2023, then crashed by 2,346bps to -10.47% in 2024.